BIO-Key International, Inc., a company that engages in the development and marketing of fingerprint biometric technology and software solutions in the United States, recently announced the successful deployment by Summa Health System for BIO-Key’s fingerprint biometrics for compliance with strong authentication, as is required by the Ohio State Board of Pharmacy.
Summa Health System is one of the biggest integrated healthcare delivery systems in the state of Ohio and surrounds a network of community based health centers and hospitals, a health plan, an entrepreneurial entity, a physician hospital organization, medical education and research, and numerous foundations. Summa is nationally known for its excellence in care of patients and for its outstanding approaches to healthcare delivery and represents 2,000+ licensed, inpatient beds on numerous hospital campuses.
“Our mission is to provide the highest-quality, compassionate care to our patients and to contribute to a healthier community,” said Charles Ross, M.D., chief medical information officer at Summa Health System. “Upgrading from our older L-1/Identix fingerprint identification system to BIO-key’s solution was fast and easy because we were able to utilize all of the existing Identix biometric fingerprint readers that our staff was already trained and comfortable in using. Also, not having to replace our existing fingerprint readers represented a significant savings to our organization,” added Ross.
“BIO-key’s solution provides Summa with greater flexibility since we offer complete reader interoperability and as their system evolves and grows, Summa can add fingerprint readers from any of the major fingerprint reader manufacturers that can be used interchangeably with each other and their existing L1-Identix readers,” commented Mike DePasquale, CEO of BIO-key International. “Our biometric fingerprint identification complies with the Ohio Pharmacy Board two-factor authentication requirements.”
For more information on BIO-Key International, visit www.bio-key.com
Let us hear your thoughts below:
